Date: 2009-02-06 08:51:47Medicine Intellectual property law Monopoly Pharmaceutical sciences Sulfoxides Omeprazole Supplementary protection certificate Test data exclusivity Astra AB Proton pump inhibitors AstraZeneca Pharmacology | | Antitrust AstraZeneca: the first abuse case in the pharmaceutical sector Niklas FAGERLUND and Søren Bo RASMUSSEN, Directorate-General Competition, unit B-2 1. IntroductionAdd to Reading ListSource URL: ec.europa.euDownload Document from Source Website File Size: 92,25 KBShare Document on Facebook
|